Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: cisplatin|DRUG: bevacizumab|DRUG: doxorubicin|DRUG: cyclophosphamide|DRUG: paclitaxel
Sponsor: Massachusetts General Hospital
Collaborators: Dana-Farber Cancer Institute|Beth Israel Deaconess Medical Center|Brigham and Women's Hospital|Genentech, Inc.